Carboxylic acid reductase-dependent biosynthesis of eugenol and related allylphenols.

Allylphenol Bioconversion Carboxylic acid reductase Escherichia coli Eugenol Monolignol Phenylpropanoid

Journal

Microbial cell factories
ISSN: 1475-2859
Titre abrégé: Microb Cell Fact
Pays: England
ID NLM: 101139812

Informations de publication

Date de publication:
18 Nov 2023
Historique:
received: 30 08 2023
accepted: 07 11 2023
medline: 27 11 2023
pubmed: 19 11 2023
entrez: 19 11 2023
Statut: epublish

Résumé

(Hydroxy)cinnamyl alcohols and allylphenols, including coniferyl alcohol and eugenol, are naturally occurring aromatic compounds widely utilised in pharmaceuticals, flavours, and fragrances. Traditionally, the heterologous biosynthesis of (hydroxy)cinnamyl alcohols from (hydroxy)cinnamic acids involved CoA-dependent activation of the substrate. However, a recently explored alternative pathway involving carboxylic acid reductase (CAR) has proven efficient in generating the (hydroxy)cinnamyl aldehyde intermediate without the need for CoA activation. In this study, we investigated the application of the CAR pathway for whole-cell bioconversion of a range of (hydroxy)cinnamic acids into their corresponding (hydroxy)cinnamyl alcohols. Furthermore, we sought to extend the pathway to enable the production of a variety of allylphenols and allylbenzene. By screening the activity of several heterologously expressed enzymes in crude cell lysates, we identified the combination of Segniliparus rugosus CAR (SrCAR) and Medicago sativa cinnamyl alcohol dehydrogenase (MsCAD2) as the most efficient enzymatic cascade for the two-step reduction of ferulic acid to coniferyl alcohol. To optimise the whole-cell bioconversion in Escherichia coli, we implemented a combinatorial approach to balance the gene expression levels of SrCAR and MsCAD2. This optimisation resulted in a coniferyl alcohol yield of almost 100%. Furthermore, we extended the pathway by incorporating coniferyl alcohol acyltransferase and eugenol synthase, which allowed for the production of eugenol with a titre of up to 1.61 mM (264 mg/L) from 3 mM ferulic acid. This improvement in titre surpasses previous achievements in the field employing a CoA-dependent coniferyl alcohol biosynthesis pathway. Our study not only demonstrated the successful utilisation of the CAR pathway for the biosynthesis of diverse (hydroxy)cinnamyl alcohols, such as p-coumaryl alcohol, caffeyl alcohol, cinnamyl alcohol, and sinapyl alcohol, from their corresponding (hydroxy)cinnamic acid precursors but also extended the pathway to produce allylphenols, including chavicol, hydroxychavicol, and methoxyeugenol. Notably, the microbial production of methoxyeugenol from sinapic acid represents a novel achievement. The combination of SrCAR and MsCAD2 enzymes offers an efficient enzymatic cascade for the production of a wide array of (hydroxy)cinnamyl alcohols and, ultimately, allylphenols from their respective (hydroxy)cinnamic acids. This expands the range of value-added molecules that can be generated using microbial cell factories and creates new possibilities for applications in industries such as pharmaceuticals, flavours, and fragrances. These findings underscore the versatility of the CAR pathway, emphasising its potential in various biotechnological applications.

Sections du résumé

BACKGROUND BACKGROUND
(Hydroxy)cinnamyl alcohols and allylphenols, including coniferyl alcohol and eugenol, are naturally occurring aromatic compounds widely utilised in pharmaceuticals, flavours, and fragrances. Traditionally, the heterologous biosynthesis of (hydroxy)cinnamyl alcohols from (hydroxy)cinnamic acids involved CoA-dependent activation of the substrate. However, a recently explored alternative pathway involving carboxylic acid reductase (CAR) has proven efficient in generating the (hydroxy)cinnamyl aldehyde intermediate without the need for CoA activation. In this study, we investigated the application of the CAR pathway for whole-cell bioconversion of a range of (hydroxy)cinnamic acids into their corresponding (hydroxy)cinnamyl alcohols. Furthermore, we sought to extend the pathway to enable the production of a variety of allylphenols and allylbenzene.
RESULTS RESULTS
By screening the activity of several heterologously expressed enzymes in crude cell lysates, we identified the combination of Segniliparus rugosus CAR (SrCAR) and Medicago sativa cinnamyl alcohol dehydrogenase (MsCAD2) as the most efficient enzymatic cascade for the two-step reduction of ferulic acid to coniferyl alcohol. To optimise the whole-cell bioconversion in Escherichia coli, we implemented a combinatorial approach to balance the gene expression levels of SrCAR and MsCAD2. This optimisation resulted in a coniferyl alcohol yield of almost 100%. Furthermore, we extended the pathway by incorporating coniferyl alcohol acyltransferase and eugenol synthase, which allowed for the production of eugenol with a titre of up to 1.61 mM (264 mg/L) from 3 mM ferulic acid. This improvement in titre surpasses previous achievements in the field employing a CoA-dependent coniferyl alcohol biosynthesis pathway. Our study not only demonstrated the successful utilisation of the CAR pathway for the biosynthesis of diverse (hydroxy)cinnamyl alcohols, such as p-coumaryl alcohol, caffeyl alcohol, cinnamyl alcohol, and sinapyl alcohol, from their corresponding (hydroxy)cinnamic acid precursors but also extended the pathway to produce allylphenols, including chavicol, hydroxychavicol, and methoxyeugenol. Notably, the microbial production of methoxyeugenol from sinapic acid represents a novel achievement.
CONCLUSION CONCLUSIONS
The combination of SrCAR and MsCAD2 enzymes offers an efficient enzymatic cascade for the production of a wide array of (hydroxy)cinnamyl alcohols and, ultimately, allylphenols from their respective (hydroxy)cinnamic acids. This expands the range of value-added molecules that can be generated using microbial cell factories and creates new possibilities for applications in industries such as pharmaceuticals, flavours, and fragrances. These findings underscore the versatility of the CAR pathway, emphasising its potential in various biotechnological applications.

Identifiants

pubmed: 37980525
doi: 10.1186/s12934-023-02246-4
pii: 10.1186/s12934-023-02246-4
pmc: PMC10656918
doi:

Substances chimiques

carboxylic acid reductase EC 1.3.99.-
ferulic acid AVM951ZWST
coniferyl alcohol E7SM92591P
methoxyeugenol 0
Eugenol 3T8H1794QW
Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

238

Subventions

Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408
Organisme : H2020 Industrial Leadership
ID : 814408

Informations de copyright

© 2023. The Author(s).

Références

Int J Mol Sci. 2021 Apr 01;22(7):
pubmed: 33916044
Microb Biotechnol. 2021 May;14(3):1120-1129
pubmed: 33710766
Plant Mol Biol. 1999 Sep;41(2):279-91
pubmed: 10579494
Metab Eng. 2018 Jan;45:158-170
pubmed: 29233745
Plant J. 2007 Jan;49(2):265-75
pubmed: 17241449
Green Chem. 2019 May 15;20(3):658-663
pubmed: 31168294
Commun Biol. 2018 Jun 8;1:66
pubmed: 30271948
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10128-33
pubmed: 16782809
Metab Eng. 2020 May;59:44-52
pubmed: 32004707
Chembiochem. 2019 Apr 1;20(7):949-954
pubmed: 30537293
Microb Cell Fact. 2017 Jun 12;16(1):104
pubmed: 28606145
BMC Plant Biol. 2018 Jan 2;18(1):1
pubmed: 29291729
Nat Methods. 2017 Feb;14(2):153-159
pubmed: 27992409
Front Plant Sci. 2021 Aug 17;12:704697
pubmed: 34484267
Arch Biochem Biophys. 2014 Jan 1;541:37-46
pubmed: 24189289
Bioinformatics. 2018 Jul 1;34(13):2327-2329
pubmed: 29949952
Metab Eng. 2017 Jan;39:102-109
pubmed: 27816771
Nat Commun. 2023 Jul 24;14(1):4448
pubmed: 37488111
J Biol Eng. 2011 Sep 20;5:12
pubmed: 21933410
J Agric Food Chem. 2018 Mar 14;66(10):2259-2272
pubmed: 28006900
Metab Eng. 2020 Jul;60:168-182
pubmed: 32335188
Polymers (Basel). 2019 Jul 12;11(7):
pubmed: 31336845
J Am Chem Soc. 2014 Aug 20;136(33):11644-54
pubmed: 25076127
Metab Eng. 2011 Sep;13(5):527-31
pubmed: 21689779
J Bacteriol. 1998 Jun;180(11):2915-23
pubmed: 9603882
Phytochemistry. 2003 Jan;62(2):139-46
pubmed: 12482448
J Biotechnol. 2020 Jan 10;307:107-113
pubmed: 31689469
Bioinformatics. 2018 Jun 15;34(12):2153-2154
pubmed: 29425325

Auteurs

Erik K R Hanko (EKR)

Manchester Institute of Biotechnology, Faculty of Science and Engineering, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

Kris Niño G Valdehuesa (KNG)

Manchester Institute of Biotechnology, Faculty of Science and Engineering, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

Koen J A Verhagen (KJA)

dsm-firmenich, Science & Research, P.O. Box 1, Delft, 2600 MA, The Netherlands.

Jakub Chromy (J)

Manchester Institute of Biotechnology, Faculty of Science and Engineering, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

Ruth A Stoney (RA)

Manchester Institute of Biotechnology, Faculty of Science and Engineering, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

Jeremy Chua (J)

Manchester Institute of Biotechnology, Faculty of Science and Engineering, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

Cunyu Yan (C)

Manchester Institute of Biotechnology, Faculty of Science and Engineering, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.

Johannes A Roubos (JA)

dsm-firmenich, Science & Research, P.O. Box 1, Delft, 2600 MA, The Netherlands.

Joep Schmitz (J)

dsm-firmenich, Science & Research, P.O. Box 1, Delft, 2600 MA, The Netherlands.

Rainer Breitling (R)

Manchester Institute of Biotechnology, Faculty of Science and Engineering, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. rainer.breitling@manchester.ac.uk.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Ethiopia Humans Cross-Sectional Studies Qualitative Research Health Facilities
Models, Statistical Machine Learning Drug Recalls Pharmaceutical Preparations Artificial Intelligence
Humans Digital Technology Equipment and Supplies Pharmaceutical Preparations

Classifications MeSH